Pomalidomide, cyclophosphamide and dexamethasone in case of suboptimal response to pomalidomide and dexamethasone alone in relapsed and/or refractory multiple myeloma : Final results of the GMMG-PERSPECTIVE trial

Authors :: Weisel, K.
Salwender, H.
Scheid, C.
Zago, M.
Besemer, B.
Hänel, M.
Dürig, Jan
Munder, M.
Lindemann, H.-W.
Seckinger, A.
Kunz, C.
Benner, A.
Hose, D.
Jauch, A.
Kanz, L.
Goldschmidt, H.
GMMG
Publication Year :: 2018

Tools